EUVIMEDEUVIMED entdecken
Open Access

Targeting Skin Barrier Function in Atopic Dermatitis

Ellen H van den Bogaard, Peter M Elias, Elena Goleva, Evgeny Berdyshev, Jos P H Smits, Simon G Danby, Michael J Cork, Donald Y M Leung

The Journal of Allergy and Clinical Immunology: In Practice · 2023-05 · 11 (5) · 1335-1346

DOI: 10.1016/j.jaip.2023.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023-05. Verfasst von Ellen H van den Bogaard und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIEHS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is the most common chronic inflammatory skin disease in the general population. Skin barrier dysfunction is the central abnormality leading to AD. The cause of skin barrier dysfunction is complex and rooted in genetic mutations, interactions between the immune pathway activation and epithelial cells, altered host defense mechanisms, as well as environmental influences that cause epithelial cell activation and release of alarmins (such as thymic stromal lymphopoietin) that can activate the type 2 immune pathway, including generation of interleukins 4 and 13, which induces defects in the skin barrier and increased allergic inflammation. These inflammatory pathways are further influenced by environmental factors including the microbiome (especially Staphylococcus aureus), air pollution, stress, and other factors. As such, AD is a syndrome involving multiple phenotypes, all of which have in common skin barrier dysfunction as a key contributing factor. Understanding mechanisms leading to skin barrier dysfunction in AD is pointing to the development of new topical and systemic treatments in AD that helps keep skin borders secure and effectively treat the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansSkinCytokinesInflammationThymic Stromal Lymphopoietin

Stichwörter der Autor:innen

Aryl hydrocarbon receptorAtopic dermatitisBarrier repairDupilumabEczemaInterleukin-13Interleukin-4MoisturizerStaphylococcus aureus

Substanzen

CytokinesThymic Stromal Lymphopoietin

Autor:innen und Institutionen

  • Department of Dermatology, Radboud Institute for Molecular Life Science, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Dermatology, University of California San Francisco and VA Medical Center, San Francisco, Calif.
  • Department of Pediatrics, Division of Pediatric Allergy and Immunology, National Jewish Health, Denver, Colo.
  • Department of Pulmonology, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, Colo.
  • Department of Infection, Immunity and Cardiovascular Disease, The Medical School at The University of Sheffield, Beech Hill Road, Sheffield, UK.
  • Department of Pediatrics, Division of Pediatric Allergy and Immunology, National Jewish Health, Denver, Colo. Electronic address: Leungd@njhealth.org.

Förderung

  • NIAMS NIH HHS
  • NIEHS NIH HHS
  • NIAID NIH HHS
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek
  • National Institutes of Health
  • LEO Fondet
  • National Institute of Environmental Health Sciences
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases

Zitieren

APA

van den Bogaard, E. H., Elias, P. M., Goleva, E., Berdyshev, E., Smits, J. P. H., Danby, S. G., Cork, M. J., & Leung, D. Y. M. (2023). Targeting Skin Barrier Function in Atopic Dermatitis. The Journal of Allergy and Clinical Immunology: In Practice, 11(5), 1335-1346. https://doi.org/10.1016/j.jaip.2023.02.005

Vancouver

van den Bogaard EH, Elias PM, Goleva E, Berdyshev E, Smits JPH, Danby SG, et al. Targeting Skin Barrier Function in Atopic Dermatitis. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(5):1335-1346. doi:10.1016/j.jaip.2023.02.005

BibTeX
@article{vandenBogaard2023,
  author = {van den Bogaard, Ellen H and Elias, Peter M and Goleva, Elena and Berdyshev, Evgeny and Smits, Jos P H and Danby, Simon G and Cork, Michael J and Leung, Donald Y M},
  title = {Targeting Skin Barrier Function in Atopic Dermatitis},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  volume = {11},
  number = {5},
  pages = {1335--1346},
  doi = {10.1016/j.jaip.2023.02.005}
}
Kostenlos starten →